563 related articles for article (PubMed ID: 25668134)
1. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature.
Blake EA; Kodama M; Yunokawa M; Ross MS; Ueda Y; Grubbs BH; Matsuo K
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():97-105. PubMed ID: 25668134
[TBL] [Abstract][Full Text] [Related]
2. Feto-maternal outcomes of pregnancy complicated by ovarian malignant germ cell tumor: a systematic review of literature.
Kodama M; Grubbs BH; Blake EA; Cahoon SS; Murakami R; Kimura T; Matsuo K
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():145-56. PubMed ID: 25150953
[TBL] [Abstract][Full Text] [Related]
3. Feto-maternal outcomes of pregnancy complicated by ovarian sex-cord stromal tumor: a systematic review of literature.
Blake EA; Carter CM; Kashani BN; Kodama M; Mabuchi S; Yoshino K; Matsuo K
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():1-7. PubMed ID: 24439718
[TBL] [Abstract][Full Text] [Related]
4. Feto-maternal outcome of pregnancy complicated by vulvar cancer: a systematic review of literature.
Matsuo K; Whitman SA; Blake EA; Conturie CL; Ciccone MA; Jung CE; Takiuchi T; Nishimura M
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():216-23. PubMed ID: 24768232
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
6. Endometrioid ovarian carcinoma during pregnancy presenting with acute rupture.
Gottheil S; McGee J
J Obstet Gynaecol Can; 2013 Nov; 35(11):1020-1022. PubMed ID: 24246402
[TBL] [Abstract][Full Text] [Related]
7. Feto-maternal outcomes of pregnancy complicated by Krukenberg tumor: a systematic review of literature.
Kodama M; Moeini A; Machida H; Blake EA; Grubbs BH; Matsuo K
Arch Gynecol Obstet; 2016 Sep; 294(3):589-98. PubMed ID: 26897498
[TBL] [Abstract][Full Text] [Related]
8. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysis.
Previs R; Leath CA; Coleman RL; Herzog TJ; Krivak TC; Brower SL; Tian C; Secord AA
Gynecol Oncol; 2015 Aug; 138(2):267-71. PubMed ID: 26037898
[TBL] [Abstract][Full Text] [Related]
10. Clinical management of epithelial ovarian cancer during pregnancy.
Grimm D; Woelber L; Trillsch F; Keller-v Amsberg G; Mahner S
Eur J Cancer; 2014 Mar; 50(5):963-71. PubMed ID: 24462638
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer during pregnancy.
Gezginç K; Karataylı R; Yazıcı F; Acar A; Celik C; Capar M
Int J Gynaecol Obstet; 2011 Nov; 115(2):140-3. PubMed ID: 21872237
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in epithelial ovarian cancer: A population-based study.
Chang LC; Huang CF; Lai MS; Shen LJ; Wu FL; Cheng WF
PLoS One; 2018; 13(3):e0194993. PubMed ID: 29579127
[TBL] [Abstract][Full Text] [Related]
13. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
[TBL] [Abstract][Full Text] [Related]
14. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC).
Kolomainen DF; Daponte A; Barton DP; Pennert K; Ind TE; Bridges JE; Shepherd JH; Gore ME; Kaye SB; Riley J
Gynecol Oncol; 2012 Apr; 125(1):31-6. PubMed ID: 22082991
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer.
Park JY; Heo EJ; Lee JW; Lee YY; Kim TJ; Kim BG; Bae DS
J Gynecol Oncol; 2016 Mar; 27(2):e20. PubMed ID: 26768783
[TBL] [Abstract][Full Text] [Related]
17. [Pathological characteristics and prognosis of 664 patients with epithelial ovarian cancer: a retrospective analysis].
Hou MM; Chen Y; Wu YK; Xi MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):859-62, 875. PubMed ID: 25341355
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and prognostic inflection points among long-term survivors of advanced epithelial ovarian cancer.
Son JH; Kong TW; Paek J; Song KH; Chang SJ; Ryu HS
Int J Gynaecol Obstet; 2017 Dec; 139(3):352-357. PubMed ID: 28857180
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer in pregnancy: a clinicopathologic analysis of 22 cases and review of the literature.
Zhao XY; Huang HF; Lian LJ; Lang JH
Int J Gynecol Cancer; 2006; 16(1):8-15. PubMed ID: 16445603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
